Elite in Progressive Supranuclear Palsy
Check Dr. Irene Litvan's experience treating your condition:
About Dr. Irene Litvan

Irene Litvan is a Neurologist in San Diego, California. Litvan has been practicing medicine for over 44 years and is rated as an Elite expert by MediFind in the treatment of Progressive Supranuclear Palsy. She is also highly rated in 25 other conditions, according to our data. Her top areas of expertise are Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Brown Syndrome, and Deep Brain Stimulation. She is licensed to treat patients in Kentucky. Litvan is currently accepting new patients.

Her clinical research consists of co-authoring 225 peer reviewed articles and participating in 12 clinical trials in the past 15 years. In particular, she has co-authored 79 articles and participated in 5 clinical trials in the study of Progressive Supranuclear Palsy.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Irene Litvan it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
4510 Executive Dr, San Diego, CA 92121
Background & Education
Graduate Institution
Other, 1979
Psychiatry & Neurology in KY
Hospital Affiliations
UC San Diego Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Real-Time Levodopa Monitoring for Improved Management of Parkinson Disease
Randomized, Double-Blind, Placebo-controlled Safety Study of Glial Cell Line-Derived Neurotrophic Factor Gene Transfer (AAV2-GDNF) in Multiple System Atrophy
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
The Four-Repeat Tauopathy Neuroimaging Initiative
Parkinson's Foundation: PD Generation: Mapping the Future of Parkinson's Disease
A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)
18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia
The Parkinson's Progression Markers Initiative (PPMI)
Genetic and Environmental Risk Factors for PSP
View 6 Less Clinical Trials -

226 Total Publications

Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors